Alkermes, Inc.Waltham, MA United States
Company Description
Alkermes is working some medicinal alchemy. The firm uses its proprietary drug-delivery systems to make compounds that require less frequent dosing or provide more targeted delivery. Focusing on widespread diseases like diabetes, central nervous system disorders, and addiction, it has a couple of drugs on the market that use its injectable extended-release technology, which lets patients take a drug once or twice a month, rather than once or twice a day. One such drug is Risperdal Consta, a long-acting version of
| 852 Winter St. | Phone: 781-609-6000 | http://www.alkermes.com |
| Waltham, MA 02451 | 
Map This Company | |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Alkermes, Inc. Rankings
Executives
| 49 executives listed for Alkermes, Inc.'s Waltham, MA location. | ||
| Chairman, President, and CEO | Richard Pops | |
|---|---|---|
| SVP, COO, and Chief Risk Officer | Gordon Pugh | |
| SVP, CFO, and Treasurer | James Frates | |
Financials
| Company Type | PrivateHeadquarters |
|---|---|
| Fiscal Year-End | March |
| 2011 Employees | 600 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Alkermes, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
